Medtronic, Genzyme Lead U.S. Orthopedic Biomaterials Market Is Projected to Reach $3.88 Billion by 2021

Share Article

Hyaluronic acid viscosupplementation used in the treatment of osteoarthritis accounts for the majority of the market growth, reports iData Research.

“Sales of single injection hyaluronic acid (HA) products like Gel-One® and Monovisc™ increase as older consumers require more frequent osteoarthritis care."

According to a report by iData Research, the leading global authority in medical device market research, the U.S. orthopedic biomaterials market is expected to grow to nearly $3.88 billion by 2021. Hyaluronic acid viscosupplementation used in the treatment of osteoarthritis to delay total knee replacement, accounts for the majority of the market growth which is expected to reach nearly a billion dollars by 2017.

“Sales of single injection hyaluronic acid (HA) products like Gel-One® and Monovisc™ increase as older consumers require more frequent osteoarthritis care,” explains Dr. Kamran Zamanian of iData. “The market is shifting from five injections to three and further to single injection despite a slightly higher average selling price for the latter.”

The hyaluronic acid viscosupplementation market consists of injections which provide pain relief for osteoarthritis of the knee. These treatments occur once a week with varying amounts of injections depending on the amount of pain management required. This is why three injection and more recently single injection treatments have dominated the market. The market is shifting to single injection products, but the multi-injection market will still remain a leader over the next few years.

The current leader in the orthopedic biomaterials market, Medtronic has over 20% market share with their line of growth factor bone graft products. However, their main competitor, Genzyme currently holds over 10% of the orthopedic biomaterials market through their majority market share in the hyaluronic acid viscosupplementation segment.

For Further Information
The full U.S. Orthopedic Biomaterials report provides a comprehensive market analysis including units sold, market value, forecasts, as well as a detailed competitive market analysis of major players’ success strategies in each market and segment.

Markets covered include:

  •     Spinous Process Fixation Market
  •     Facet Fixation Market,
  •     MIS Interbody Fusion Market
  •     MIS Pedicle Screw Market
  •     MIS Sacroiliac Joint Fusion Market
  •     Spine Endoscope Market

Register or email at info(at)idataresearch(dot)net for a complimentary U.S. Orthopedic Biomaterials Market - 2015 report synopsis.

About iData Research
iData Research is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Diabetes Drugs, Diabetes Devices, Pharmaceuticals, Anesthesiology, Wound Management, Orthopedics, Cardiovascular, Ophthalmics, Endoscopy, Gynecology, Urology and more.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Caroline Lau
iData Research
+1 604-266-6933 Ext: 215
Email >
@iDataResearch
Follow >
iData Research
Like >
iData Research

Follow us on
Visit website